Notice NOT-NS-22-032 from the NIH Guide for Grants and Contracts

Notice NOT-TW-21-008 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-AI-21-075 from the NIH Guide for Grants and Contracts. To expand our understanding of protozoan parasite persistence mechanisms and provide research tools and strategies to enable identification and credentialing of novel treatments for persistent protozoan pathogens.

Funding Opportunity RFA-MH-22-105 from the NIH Guide for Grants and Contracts. Adolescents have some of the poorest outcomes along the HIV care continuum around the world. Differentiated care or differentiated service delivery has great promise to meet the needs of adolescents living with HIV and reduce unnecessary burdens on the healthcare system. Differentiated care or differentiated service delivery is defined as client-centered approaches that simplify and adapt HIV services across the care continuum, in ways that both better serve the needs of adolescents living with HIV and reduce unnecessary burdens on the health system. Most of the data on differentiated care has been limited to ART delivery for stable adults in high-prevalence settings in sub-Saharan Africa. A recent supplement to the Journal of the International AIDS Society on differentiated care and HIV provides data to support these new approaches to providing care to PLHIV; however, programs rarely target the unique needs of ALWH.

Funding Opportunity RFA-MH-22-125 from the NIH Guide for Grants and Contracts. This initiative encourages research focused on development of and testing the effectiveness of intervention approaches that utilize enhanced interpersonal strategies to strengthen and compliment efforts in suicide prevention. Existing suicide prevention practices emphasize safety management protocols and intrapersonal coping skills but tend to focus less on strategies addressing interpersonal targets that contribute to suicide risk. The intent of this initiative is to develop and/or utilize interpersonal treatment strategies that reduce risk by enhancing perceived social supports and connections that contribute to life-affirming beliefs, intentions, and behaviors, in ways consistent with conceptual models of suicide risk, to enhance the effectiveness of existing evidence-based treatments and develop new approaches, as indicated.

Notice NOT-OD-22-005 from the NIH Guide for Grants and Contracts

Notice NOT-OD-22-006 from the NIH Guide for Grants and Contracts

Notice NOT-AI-22-008 from the NIH Guide for Grants and Contracts

Notice NOT-AI-21-080 from the NIH Guide for Grants and Contracts

Notice NOT-AI-21-081 from the NIH Guide for Grants and Contracts

Notice NOT-DA-21-089 from the NIH Guide for Grants and Contracts

Notice NOT-CA-22-002 from the NIH Guide for Grants and Contracts

Notice NOT-DK-21-015 from the NIH Guide for Grants and Contracts

£42,527-£50,942 per annum: https://jobs.sanger.ac.uk/vacancy/senior-software-developers-461812.html: Two opportunities have arisen to join our world leading software development and bioinformatics team at the Wellcome Sanger Institute just outside ... Cambridge, Cambridgeshire

Funding Opportunity RFA-NS-21-025 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NIH Blueprint for Neuroscience Research R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Courses for Skills Development. This FOA solicits Research Education Grant (R25) applications to develop and implement short courses on neurotherapeutics development for academic neuroscientists. The short courses should provide participants with a sufficient overview of the neurotherapeutics development process to (1) understand the steps required for therapeutics development, (2) anticipate and overcome common challenges in the process, and (3) interact effectively with collaborators who have expertise in various aspects of therapeutics development. The short courses should primarily target independent academic neuroscience researchers and senior post-doctoral fellows interested in incorporating treatment development into their research programs.

Notice NOT-DA-21-086 from the NIH Guide for Grants and Contracts

£60000 - £80000 per annum: Hyper Recruitment Solutions (HRS): We are currently looking for a Bioinformatics Manager to join a n exciting multi cultural biotech based in the Cambridge area. As the Bioinformatics Manager... Cambridge

£40000 - £60000 per annum: Hyper Recruitment Solutions (HRS): We are currently looking for a Bioinformatics Scientist to join a leading biotech company based in the Cambridge area. As the Bioinformatics Scientist you will... Cambridgeshire

£40000 - £50000 per annum: Hyper Recruitment Solutions (HRS): We are currently looking for a Bioinformatics Pipeline Developer to join a leading Biotech company based in the Cambridgeshire area. As the Bioinformatics Pipeline Developer... Cambridge

Funding Opportunity RFA-AI-21-070 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support discovery and design of novel Group A Streptococcus (GAS) vaccine candidates and their advancement into preclinical evaluation for broad protection against GAS infections.